Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.
Discovering and developing innovative therapeutics for CNS disorders
Investors
Reports, Presentations & Fact sheet - 2008
| Title: | |
|---|---|
R&D day presentation November 4/7, 200807/11/2008 |  |
Half - Year Report 200819/09/2008 | |
Corporate information (fact sheet)28/08/2008 | |
Ralfinamide presentation - conference call MP3 File16/04/2008 | |
Ralfinamide presentation16/04/2008 | |
60th AAN Meeting poster (ralfinamide)16/04/2008 | |
The Nerve Compression and Nerve Entrapment Epidemiology (leaflet)16/04/2008 | |
Media conference - 2007 results MP3 File27/03/2008 | |
Annual Report 200727/03/2008 | |
Media conference - 2007 results27/03/2008 | |
Progetto di Bilancio d'Esercizio27/03/2008 | |
Acquisition of Hunter Fleming Ltd Conference call MP3 Audio File12/02/2008 | |
Acquisition of Hunter-Fleming Conference Call11/02/2008 | |